Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Wilms’ tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p

Fig. 1

WT1 is highly expressed and its upregulation favors poor prognosis in lung cancer. (A) WT1 gene expression in different primary tumours and corresponding normal tissues by Metabolic gEne RApid Visualizer. (B) Comparison of WT1 gene expression in different subtypes of NSCLC tissues with normal lung tissues analyzed by Oncomine. Panels 1, 3, 5: normal lung tissues (n = 65). Panel 2: LUAD (n = 45). Panel 4: LUSC (n = 27). Panel 6: LCLC (n = 19). (C) WT1 protein expression in normal lung, LUAD and LUSC revealed by IHC from Human Protein Atlas. (D) Kaplan-Meier survival analysis of WT1 gene expression with NSCLC patient overall survival (OS), progression free survival (PFS) and post-progression survival (PPS) by Kaplan-Meier plotter

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us